To evaluate the potential role of PCYT2, a key rate-limiting enzyme of PE synthesis pathway in CRC progression, we analyzed PCYT2 protein expression difference between tumor and normal tissue in the publicly available datasets. The gene discussed is PCYT2; the disease is colorectal carcinoma.